97 related articles for article (PubMed ID: 18536579)
1. NF-kappaB in the pathogenesis and treatment of multiple myeloma.
Li ZW; Chen H; Campbell RA; Bonavida B; Berenson JR
Curr Opin Hematol; 2008 Jul; 15(4):391-9. PubMed ID: 18536579
[TBL] [Abstract][Full Text] [Related]
2. Positioning NK-kappaB in multiple myeloma.
Klein B
Blood; 2010 Apr; 115(17):3422-4. PubMed ID: 20430962
[No Abstract] [Full Text] [Related]
3. Unique cutaneous metastasis of multiple myeloma.
Bourgeois J; Charles S; Huang E; Rothwell W
JAAD Case Rep; 2024 May; 47():84-86. PubMed ID: 38659473
[No Abstract] [Full Text] [Related]
4. Multiple myeloma.
Collins CD
Cancer Imaging; 2004 Jan; 4 Spec No A(Spec No A):S47-53. PubMed ID: 18215975
[No Abstract] [Full Text] [Related]
5. A critical role for the NFkB pathway in multiple myeloma.
Demchenko YN; Kuehl WM
Oncotarget; 2010 May; 1(1):59-68. PubMed ID: 20890394
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.
Hideshima T; Ikeda H; Chauhan D; Okawa Y; Raje N; Podar K; Mitsiades C; Munshi NC; Richardson PG; Carrasco RD; Anderson KC
Blood; 2009 Jul; 114(5):1046-52. PubMed ID: 19436050
[TBL] [Abstract][Full Text] [Related]
7. The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma.
Vrábel D; Pour L; Ševčíková S
Blood Rev; 2019 Mar; 34():56-66. PubMed ID: 30501907
[TBL] [Abstract][Full Text] [Related]
8. Severe Lenalidomide-Associated Hyperbilirubinemia.
Gildea DT; Roswarski JL
Cureus; 2023 Jan; 15(1):e34408. PubMed ID: 36874759
[TBL] [Abstract][Full Text] [Related]
9. The Role of Chaperone-Mediated Autophagy in Bortezomib Resistant Multiple Myeloma.
Nikesitch N; Rebeiro P; Ho LL; Pothula S; Wang XM; Khong T; Quek H; Spencer A; Lee CS; Roberts TL; Ling SCW
Cells; 2021 Dec; 10(12):. PubMed ID: 34943972
[No Abstract] [Full Text] [Related]
10. Multiple Myeloma Relapse Is Associated with Increased NFκB Pathway Activity and Upregulation of the Pro-Survival BCL-2 Protein BFL-1.
Spaan I; van de Stolpe A; Raymakers RA; Peperzak V
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572895
[TBL] [Abstract][Full Text] [Related]
11. JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells
Zhang Z; Ye C; Liu J; Xu W; Wu C; Yu Q; Xu X; Zeng X; Jin H; Wu Y; Yan H
Cancer Biol Med; 2021 Sep; 19(5):651-68. PubMed ID: 34570444
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia.
Sorrentino VG; Thota S; Gonzalez EA; Rameshwar P; Chang VT; Etchegaray JP
Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358067
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolidinedithiocarbamic Acid Ammonium Salt Inhibits Apoptosis and Phenotypic Transformation of Co-Culture of Myeloma Cells and Renal Tubular Epithelial Cells by Reducing the Secretion of Light Chain Protein.
Yu X; Bao J; Cui X; DU F; Wang Y; Bi L; Sun J; Li L
Iran J Public Health; 2020 Nov; 49(11):2078-2086. PubMed ID: 33708728
[TBL] [Abstract][Full Text] [Related]
14. Carfilzomib in Combination with Bortezomib Enhances Apoptotic Cell Death in B16-F1 Melanoma Cells.
Lee MS; Lim SH; Yu AR; Hwang CY; Kang I; Yeo EJ
Biology (Basel); 2021 Feb; 10(2):. PubMed ID: 33671902
[TBL] [Abstract][Full Text] [Related]
15. Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse Effects.
Pancheri E; Guglielmi V; Wilczynski GM; Malatesta M; Tonin P; Tomelleri G; Nowis D; Vattemi G
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32906684
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma.
Akhtar S; Ali TA; Faiyaz A; Khan OS; Raza SS; Kulinski M; Omri HE; Bhat AA; Uddin S
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679860
[TBL] [Abstract][Full Text] [Related]
17. Proteasome Inhibitors for the Treatment of Multiple Myeloma.
Ito S
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31979059
[TBL] [Abstract][Full Text] [Related]
18. Acute non-heparin-induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma.
Morita M; Nakanishi K; Masuda K; Yoshida K; Shimomura D; Ishida A; Shiga S; Ichiyama S
Clin Case Rep; 2019 Apr; 7(4):699-702. PubMed ID: 30997067
[TBL] [Abstract][Full Text] [Related]
19. Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma.
Mazzera L; Abeltino M; Lombardi G; Cantoni AM; Ria R; Ricca M; Saltarella I; Naponelli V; Rizzi FMA; Perris R; Corradi A; Vacca A; Bonati A; Lunghi P
Haematologica; 2019 Dec; 104(12):2465-2481. PubMed ID: 30948493
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
